Topics: Antipsychotics | Carbamazepine | Lamotrigine

A new warning now sits beneath the list of life-threatening allergic reactions that can happen with lamotrigine. The anticonvulsant is suspected of causing cardiac arrhythmias in susceptible patients by slowing ventricular conduction and widening the QRS.

Topics: PTSD

Topiramate is not first-line in PTSD, but it does have a role, particularly when alcohol use is part of the picture.

Topics: Generics | Pharmaceutical Industry

Generic recalls are on the rise: Bupropion, methylphenidate, and metformin, to name a few. Katherine Eban explains the limits of FDA oversight, and what we can do to protect our patients when quality control cones under suspicion.

Topics: COVID19 | Medical Comorbidities | Vitamin D

Vitamin D deficiency is causing everything from depression to cancer to COVID-19, at least that’s what our patients are hearing. Paul Riordan looks at the strength of that research and clarifies when to check levels and when to supplement.

Topics: Bipolar Depression | Bipolar Disorder | Bipolar II | Lithium | Medication adherence | Mood Stabilizers | retention

Textbooks tell us that patients with bipolar I disorder need to take mood stabilizers for life. But what are the real risks of stopping these medications? A new meta-analysis provides some clarity.

Topics: CME Post-Test

The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 1 CME credit.